Weight-Loss GLP-1 Use Under Scrutiny as Misuse Risks Surface
An editorial warns that inappropriate use of GLP-1–based obesity drugs—often for cosmetic aims or through illicit channels—may cause serious health outcomes, including ketosis/ketoacidosis in young Japanese patients. It calls for shifting from simply discouraging off-label use to promoting 'appropriate weight reduction' via medically supervised treatment, adequate nutrition, and stronger regulatory safeguards, noting differing Japan reimbursement rules for GLP-1 medications.